Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71286492 | 7128649 | 2 | F | 20160818 | 20090924 | 20160919 | PER | US-ASTRAZENECA-2009UW12623 | ASTRAZENECA | 0.00 | F | Y | 0.00000 | 20160919 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71286492 | 7128649 | 1 | PS | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | U | 20639 | 400 | MG | FILM-COATED TABLET | QD | ||||||
| 71286492 | 7128649 | 2 | SS | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | U | 20639 | 300 | MG | FILM-COATED TABLET | QD | ||||||
| 71286492 | 7128649 | 3 | SS | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | U | 20639 | 100 | MG | FILM-COATED TABLET | QD | ||||||
| 71286492 | 7128649 | 4 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 10 | MG | TABLET | QD |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 71286492 | 7128649 | Crying | |
| 71286492 | 7128649 | Disorientation | |
| 71286492 | 7128649 | Dyspnoea | |
| 71286492 | 7128649 | Heart rate increased | |
| 71286492 | 7128649 | Night sweats |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |